NICE accreditation for our New Drug Evaluations

17th May 2017

We are delighted to announce that following a rigorous application process, NICE has accredited the process used to produce our New Drug Evaluations (NDEs).

Our NDEs are concise, structured reviews of new drugs recently launched within the NHS. They are available on our website to stakeholders only for the first 3 months, after which they are freely accessible.

NICE accreditation demonstrates that our NDEs are produced using high quality processes and assures users of the high quality of the publication.

This is an incredible achievement for the RDTC and a welcome recognition of the high standards of our work. Our NDE process can now be counted among those of well-respected organisations such as the BNF, MHRA, SIGN and NICE itself.

All our NDEs produced using the accredited process will now display the NICE Accreditation Mark. Accreditation is valid for 5 years from March 2017.